Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

Recruiting 20 enrolled Northern Jiangsu People's Hospital

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Apixaban is effective and safe in the treatment of portal vein thrombosis Occurring more than one year after laparoscopic splenectomy.

Timeline

Start: 2026-04-01
Primary completion: 2027-09-30
Completion: 2027-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Apixaban	Small molecule	2.5 mg	Oral

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

Summary

Timeline

Drugs

Indications